The emergence of SARS-CoV-2 triggering the COVID-19 pandemic ranks as arguably the
greatest medical emergency of the last century. COVID-19 has highlighted health disparities …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly
infectious respiratory virus which is responsible for the coronavirus disease 2019 (COVID …

Summary Severe coronavirus disease 2019 (COVID-19) is characterized by overproduction
of immune mediators, but the role of interferons (IFNs) of the type I (IFN-I) or type III (IFN-III) …

Patients with blood disorders who are immune suppressed are at increased risk for infection
with severe acute respiratory syndrome coronavirus 2. Sequelae of infection can include …

After acute infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a
proportion of patients experience persistent symptoms beyond 12 weeks, termed Long …

Severe COVID-19 arises from the convergence of inadequate pre-existing immunity and a
host response that damages, rather than repairs, tissues. We outline clinical presentations of …

We have applied nuclear magnetic resonance spectroscopy based plasma phenotyping to
reveal diagnostic molecular signatures of SARS-CoV-2 infection via combined diffusional …

We sought to better understand the immune response during the immediate post-diagnosis
phase of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by identifying …

Previous studies have reported impaired humoral responses after SARS-CoV-2 mRNA
vaccination in patients with immune-mediated inflammatory diseases (IMIDs), particularly …

Aims While acute cardiovascular complications of coronavirus disease 2019 (COVID-19) are
well described, less is known about longer-term cardiac sequelae. For many individuals with …